A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)
This study has been terminated.
(The primary endpoint at 15 months was not met.)
Sponsor:
Diamyd Therapeutics AB
Information provided by (Responsible Party):
Diamyd Therapeutics AB
ClinicalTrials.gov Identifier:
NCT00723411
First received: July 24, 2008
Last updated: October 7, 2011
Last verified: October 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | August 2011 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |
No publications provided by Diamyd Therapeutics AB
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):